The present disclosure is related to apparatus and methods for delivery of fluids to a target site such as, but not limited to, bone marrow of a bone and removal of fluids from a target site.
Every year, millions of patients are treated for life threatening emergencies in the United States. Such emergencies include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, bums, and status epilepticus just to name a few. For example, according to the American Heart Association, more than 1,500,000 patients suffer from heart attacks (myocardial infarctions) every year, with over 500,000 of them dying from its devastating complications.
An essential element for treating all such emergencies is the rapid establishment of an intravenous (IV) line in order to administer drugs and fluids directly into the circulatory system. Whether in the ambulance by paramedics, or in the emergency room by emergency specialists, the goal is the same—to start an IV in order to administer life-saving drugs and fluids. To a large degree, the ability to successfully treat such critical emergencies is dependent on the skill and luck of the operator in accomplishing vascular access. While it is relatively easy to start an IV on some patients, doctors, nurses and paramedics often experience great difficulty establishing IV access in approximately 20 percent of patients. These patients are probed repeatedly with sharp needles in an attempt to solve this problem and may require an invasive procedure to finally establish an intravenous route.
A further complicating factor in achieving IV access occurs “in the field” e.g. at the scene of an accident or during ambulance transport where it is difficult to see the target and excessive motion make accessing the venous system very difficult.
In the case of patients with chronic disease or the elderly, the availability of easily-accessible veins may be depleted. Other patients may have no available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration or previous IV drug use. For these patients, finding a suitable site for administering lifesaving drugs becomes a monumental and frustrating task. While morbidity and mortality statistics are not generally available, it is known that many patients with life-threatening emergencies have died of ensuing complications because access to the vascular system with life-saving IV therapy was delayed or simply not possible. For such patients, an alternative approach is required.
In accordance with teachings of the present disclosure, an apparatus operable to deliver a quantity of fluid to a target site such as bone marrow of a bone may be provided. The apparatus may include a driver, a plunger operating and cartridge drive mechanism and a cartridge assembly having a fluid reservoir with a bone penetrating needle coupled thereto.
In another embodiment an apparatus for delivering a quantity of medication to a target site may include a driver, a plunger operating assembly or a plunger barrel having a first spring, a retractable sleeve having a second spring and a fluid reservoir with a bone penetrator attached thereto.
In still another embodiment an apparatus for delivering a quantity of fluid to bone marrow of a bone is provided that may include a powered driver having a drill shaft operable for attachment with a plunger operating and cartridge drive mechanism, a gear assembly operable to engage and rotate the drill shaft, a motor, a power supply and associated circuitry operable to power the motor. The plunger operating and cartridge drive mechanism may include a plunger operating assembly and a retractable sleeve. A cartridge assembly having a fluid reservoir along with a plunger assembly and a bone penetrating needle may be releasably engaged with the plunger operating and cartridge drive mechanism.
In another embodiment a method for delivering a quantity of medication to a target site such as, but not limited to, bone marrow of a bone may be provided including compressing or cocking a portion of a plunger operating and cartridge drive mechanism, inserting a fluid filled cartridge assembly into the cocked plunger operating and cartridge drive mechanism and penetrating into bone marrow until the plunger operating and cartridge drive mechanism injects a quantity of fluid into the bone marrow.
In a further embodiment a cartridge assembly operable to deliver medication to bone marrow of a bone may be provided with a detachable fluid reservoir, a plunger assembly, a bone penetrating needle and associated fittings. The fluid reservoir may be formed at least in part from glass, glass composites, plastic or plastic composites.
For some embodiments, a bone penetrating needle may include a hollow longitudinal bore with a closed tip at one end of the longitudinal bore. Side ports communicating with the longitudinal bore of the bone penetrating needle may be angled to block or facilitate passage of certain substances.
A more complete and thorough understanding of the present embodiments and advantages thereof may be acquired by referring to the following description taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features, and wherein:
Preferred embodiments of the disclosure and advantages are best understood by reference to
The term “fluid” may be used within this patent application to include any liquid or any mixture of liquids, particulate matter, dissolved medication and/or drugs appropriate for injection into bone marrow or other target sites. The term “fluid” may also be used within this patent application to include body fluids such as, but not limited to, blood and cells which may be withdrawn from a target site.
The terms “fluid reservoir” and “reservoir” may be used in this patent application to include any chamber, cavity, ampoule, barrel, receptacle or any other device satisfactory for use with a cartridge assembly or other apparatus incorporating teachings of the present disclosure.
Examples of apparatus operable to access bone marrow and other target sites in accordance with teachings of the present disclosure are shown generally in
Various features of the present disclosure may be described with respect to apparatus 20 as shown in
Apparatus 20, as shown in
Driver assembly 30 may include motor 34 connected to gearbox 36. Gearbox 36 may be attached to drive shaft 38 to produce rotational motion of plunger operating and cartridge drive mechanism 50. Various types of motors may be satisfactorily used to produce rotational, reciprocal or any other type of motion suitable to achieve results. In this example embodiment, motor 34 may be powered by battery pack 40. In alternative embodiments, motor 34 may be powered by electricity from a standard wall outlet, an AC to DC converter solar power generator. A compressed or wound spring, gas cartridge or any other satisfactory power source for operating a motor may also be used to operate apparatus 20.
Plunger operating and cartridge drive mechanism 50 may include first spring 51, second spring 52 and third spring 53. See
Plunger operating and cartridge drive mechanism 50 may also include rotatable housing 54, retractable sleeve 58, plunger operating assembly 82, and pawl latch assembly 110. Retractable sleeve 58 may sometimes be referred to as “spring loaded retractable sleeve 58.” Plunger operating assembly 82 may sometimes be referred to as “spring loaded plunger barrel 82.” Pawl latch assembly 110 may sometimes be referred to as “spring loaded pawl latch assembly 110.” Each of these components will be discussed later in more detail.
Drive housing 54 may be used to transmit rotational forces or drilling forces from drive shaft 38 to a cartridge assembly releasably engaged within plunger operating and cartridge drive mechanism 50. The cartridge assembly may include a fluid reservoir, a plunger assembly and a hollow, bone penetrating needle. Hollow, bone penetrating needles and hollow drill bits incorporating teachings of the present disclosure may sometimes be referred to as “bone penetrators.” Rotational and/or drilling forces from drive shaft 38 may be used to insert a bone penetrating needle into bone marrow at a selected target site.
Examples of cartridge assemblies incorporating teachings of the present disclosure are shown in
Drive housing 54 may be described as having a hollow, generally cylindrical configuration defined in part by longitudinal bore 56. Plunger operating assembly 82 may be slidably disposed within longitudinal bore 56 which extends between first end 54a and second end 54b of rotational housing 54. Portions of plunger operating assembly 82 may extend from first end 54a of rotational housing 54. See
Second end 54b of drive housing 54 may be securely engaged with drive shaft 38. For embodiments such as shown in
The exterior dimensions and configurations of drive housing 54 may be selected to allow rotation of drive housing 54 with respect to retractable sleeve 58 and other components associated with plunger operating and cartridge drive mechanism 50. Drive housing 54 may also be rotatably disposed within various components associated with housing 22 such as receiver portion 26 and interior support 23b.
Plunger operating assembly 82 may be triggered or activated to apply force to a plunger assembly associated with a cartridge assembly engaged with first end 54a of drive housing 54 to inject fluids from the cartridge assembly into bone marrow at a target site. Plunger operating assembly 82 may have a first, retracted or cocked position such as shown in
Plunger operating assembly 82 may sometimes be described as a “plunger barrel.” Plunger operating assembly 82 may have a generally cylindrical configuration defined in part by reduced outside diameter portion 84 and enlarged outside diameter portion 86. See
A plunger rod or plunger shaft extending from an associated cartridge assembly may be disposed within cavity 94. For example,
Enlarged outside diameter portion 86 (
Plunger and drive mechanism 50 may also include retractable sleeve 58 slidably disposed within housing 22. Sleeve 58 may be described as a generally elongated, hollow cylinder defined in part by first end or distal end 58a and second end or proximal 58b. Sleeve 58 may have a first, extended position such as shown in
As shown in
As shown in
For some applications, receiver portion 26 of housing 22 may include first interior support 23a and second interior support 23b. See
Second interior support 23b may have a generally circular opening formed therein (not expressly shown) and may be sized to be compatible with the outside diameter of drive housing 54. See
When a bone penetrating needle of an associated cartridge assembly is inserted into bone marrow at a target site, sleeve 58 will generally retract or slide from first end 27 of housing 22 towards second end 28 of housing 27. See
Movement of retractable sleeve 58 from its first, extended position (
Many medical devices such as syringes, hypodermic needles, catheters, IV tubing and stop cocks may include either a pin (male) or box (female) Luer type fitting. The pin end or box end may include threads which allow releasably engaging an associated medical device with other equipment having a complimentary Luer type fitting. Luer type connections may sometimes be described as Luer slips or Luer locks. Luer slips may require a half twist of an associated collar to securely engage a pin end and a box end with each other. A Luer lock functions by forming a watertight fit between a pin and a box when engaged and when twisted by a half turn or more. Luer looks frequently include a threaded looking collar on a box end which mates with ears or projections from an associated pin end to provide a more positive, locked connection. Luer connections generally form fluid tight seals. Some Luer connections may include tapered fittings.
For some applications second end 302 of hub 300 may be modified to have one or more features of such previously described Luer connections. Second end 302 and threaded connection 303 of hub 300 may be designed to accommodate attachment of various types of connectors used to communicate fluids with bone marrow or other target sites via bone penetrator 160.
As shown in
Pawl 114 may have a first position such as shown in
For some applications drive housing 54 may include opening or channel 116 extending from first end 54a. Opening or channel 116 may be sized to accommodate insertion of pivot pin 112 into associated pawl 114 and third spring 53. See
When plunger operating assembly 82 is in its first, cocked position, second lobe or second portion 114b of pawl 114 will be spaced longitudinally from ramp or trigger 70. During rotation of an associated cartridge assembly and insertion of a bone penetrator at a target site, retractable sleeve 58 will slide longitudinally relative to the exterior of drive housing 54. The longitudinal movement of retractable sleeve 58 in combination with rotation of drive housing 54 will result in ramp or trigger 70 engaging second lobe 114b which rotates pawl 114 on pivot pin 112. Such rotation results in first lobe 114a releasing or allowing plunger operating assembly 82 to move from its first, cocked position to its second, released position. As previously discussed, this movement may result in injection of fluids from cartridge assembly 130 through penetrator 160 into bone marrow at a target site.
Cartridge assemblies formed in accordance with teachings of the present disclosure may include a fluid reservoir having a generally hollow, cylindrical configuration defined in part by a first, distal end and a second, proximal end. A hub with a hollow, bone penetrating needle may be attached to the first, distal end. Portions of a plunger assembly may be slidably disposed within the fluid reservoir to force fluids contained in the fluid reservoir through an attached hollow, bone penetrating needle. The plunger assembly may include a plunger shaft and plunger piston. Portions of the plunger shaft may extend from the second, proximal end of the fluid reservoir.
For some applications, cartridge assemblies incorporating teachings of the present disclosure may be prefilled with a specific fluid using techniques associated with prefilled syringes. For other applications, cartridge assemblies incorporating teachings of the present disclosure may normally be empty until filled with a fluid or medication prior to use of each cartridge assembly. Cartridge assemblies incorporating teachings of the present disclosure will often be disposed of after a single use. However, for some applications, cartridge assemblies incorporating teachings of the present disclosure may be used multiple times and may be used at one or more target sites.
Cartridge assemblies and associated fluid reservoirs may have a wide variety of configurations and functions similar to a hypodermic syringe, an insulin syringe or a tuberculin syringe. For example, fluid reservoirs 132 and 132a (
Various features of the present disclosure may be described with respect to cartridge assemblies 130 and 130a as shown in
Cartridge assembly 130 may include barrel or fluid reservoir 132 having a generally hollow, cylindrical configuration defined in part by inside diameter 134. Barrel 132 may include first end 131 and second end 133. Hub 300 and associated hollow bone penetrating needle or bone penetrator 160 may be releasably engaged with first end 131. Barrel 132 may be formed from reusable glass, disposable plastic, glass composite, plastic composites and any other material suitable to contain fluids depending upon intended uses for cartridge assembly 130. Barrel 132 may sometimes be described as an “ampoule.”
Various types of plunger assemblies may be satisfactorily used with a cartridge assembly incorporating teachings of the present disclosure. For some applications plunger assembly 140 may include plunger shaft or plunger rod 142 and plunger piston 144. For some applications first end 145 of plunger shaft 142 may be releasably engaged with plunger piston 144. For other applications plunger shaft 142 may be securely engaged with plunger piston 144. One or more projections 146 may be formed on the outside diameter of plunger piston 144 to form a generally fluid tight, moveable seal with respect to inside diameter 134 of barrel 132. Plunger piston 144 may also function as a fluid seal or stopper to maintain any fluids contained within fluid reservoir 132 prior to loading cartridge assembly 130 into apparatus 20 or 220. Various types of elastomeric materials may be satisfactorily used to form plunger piston 144.
Plunger assembly 140 may slidably move from second end 133 of barrel 132 toward first end 131 in response to an axial force applied to plunger shaft 142. Release of plunger operating assembly 82 from its first, retracted or cocked position (
Piston 144 may include recess 148 sized to receive threaded connection 303 formed adjacent to second end 302 of hub 300. Engagement of piston 144 with the threaded connection 303 may allow disengagement of reservoir 132 from hub 300. Drive connector 150 may be securely engaged with second end 133 of barrel 132 opposite from hub 300 (
Drive connector 150 may have one or more recesses 152 formed therein and sized to receive corresponding segment 154 extending from first end 54a of drive housing 54. See for example
As shown in
As shown in
Cartridge assembly 130a as shown in
Various types of plunger assemblies may be satisfactorily used with cartridge assembly 130a. For some applications plunger assembly 140a may include plunger shaft or plunger rod 142a and plunger piston 144a. For some applications, first end 145 of plunger shaft 142a may be securely engaged with plunger piston 144a. For other applications, first end 145 may be releasably engaged with piston 144a such as shown in
One or more projections 146 may be formed on the outside diameter of plunger piston 144a to form a generally fluid tight, moveable seal with respect to inside diameter portion 134a. First end 147 of piston 144a may be configured to form a generally fluid tight seal with tapered interior surface 134b of barrel 132a. Plunger piston 144a may also function as a fluid seal or stopper to maintain fluids contained within reservoir 132a prior to inserting cartridge assembly 130a into apparatus 200 or 220. Various types of elastomeric materials may be satisfactorily used to form plunger piston 144a.
Plunger assembly 140a may slidably move from second end 133 of barrel 132a towards first end 131a in response to an axial force applied to plunger shaft 142a. Release of plunger operating assembly 82 from its first, retracted position allows first spring or plunger spring 51 to apply an axial force or a longitudinal force to move piston 144a from its first position adjacent to second end 133 to a second position which forms a generally fluid tight seal with tapered, inside diameter portion 134b of barrel 132a.
As shown in
For some applications first end 301 of hub 300a may have the general configuration of a flange. Slot or groove 304 may be formed in first end 301 and sized to receive one end of protective cover or needle cap 334. Slot or groove 304 may be used to releasably engage cover 334 with hub 300a.
As shown in
The dimensions and configuration of first end 301 of hub 300a may be varied to accommodate various target sites and/or patients. Hub 300a may be satisfactorily used with a wide variety of flanges or other configurations compatible with contacting a patient's skin. The present disclosure is not limited to hub 300a or bone penetrator 160.
For some applications a cartridge assembly may include only a single hollow bone penetrating needle. For other applications a cartridge assembly may include an outer penetrator such as a cannula or hollow bone needle or hollow drill bit (not expressly shown) and an inner penetrator such as a stylet, trocar or other removable device (not expressly shown) disposed within the outer penetrator. For some embodiments bone penetrating needles 160 and 160a may include a stylet (not expressly shown).
Penetrators may be relatively small for pediatric patients, medium-sized for adults and large for oversized adults. The length and diameter of the penetrator used in a particular application may depend upon the size of a bone to which the apparatus may be applied. Penetrators may be provided in a wide variety of configurations depending upon intended clinical purposes for insertion of the associated penetrator assembly. For example, there may be one configuration for administering drugs or fluids to a patient's bone marrow and an alternative configuration for sampling bone and/or blood from a patient. Other configurations may be appropriate for bone and/or tissue biopsy. Some penetrators may be suitable for more than one purpose. The configuration and size of a bone penetrator may also vary depending upon the target site chosen for insertion of each penetrator. The present disclosure is not limited to bone penetrators 160 or 160a.
A wide variety of hollow bone penetrating needles and hollow drills may be satisfactorily used to deliver a quantity of medication to bone marrow or other target sites in accordance with teachings of the present disclosure. Hollow, bone penetrating needles 160 and 160a as shown respectively in
Bone penetrating needles 160 and 160a may be formed of stainless steel or any other suitable material. Respective closed tips 162 suitable for drilling through a bone into associated bone marrow, may be formed on a respective first end of bone penetrators 160 and 160a. Closed tip 162 may include at least one cutting edge 170 that enables efficient drilling through bone to associated bone marrow with minimal trauma to respective outer bony cortex.
Outside diameter or exterior portion 168 of bone penetrators 160 and 160a may be selected to accommodate secure engagement with an associated hub. A second end of each bone penetrator 160 and 160a opposite from respective tip 170 may be sized to receive fluid from an attached cartridge assembly.
Bone penetrators 160 and 160a may include one or more side ports 164 for release of medication or communication of fluid with adjacent bone marrow. Side ports 164, holes in the side of bone penetrators 160 and 160a, may be configured to block passage of bone chips and debris into longitudinal bore 166. By way of example and not limitation, one way to configure side ports 164 is to angle each side port 164 in a direction that is opposite to the direction of drilling. Alternatively, bone penetrating needle 160 and 160a may include a sleeve expressly shown) that blocks passage of bony fragments into longitudinal bore 166 of bone penetrator 160 or 160a.
One of the features of such ball detent mechanisms and collet latch mechanisms includes maintaining positive engagement between an associated plunger operating and cartridge drive mechanism and an attached cartridge assembly until after an associated plunger assembly has moved from a first position to a second position. Such movement may result in fluids contained in the cartridge assembly being injected at a target site before disengagement of the cartridge assembly from the plunger operating and cartridge drive mechanism.
Plunger operating and cartridge drive mechanism 50a such as shown in
As an associated drive apparatus inserts bone penetrator 160 to a desired depth at a target site, retractable sleeve 158 will move to its second position which allows balls 172 to move radially outward into recess 170. See
In one embodiment steps such as outlined in
Once cartridge assembly 130 or 130a is engaged with drive housing 54 and plunger operating assembly 82 is in its compressed position, apparatus 20 may be considered “armed” and ready to “fire” an associated bone penetrator into a target site such as a bone overlying bone marrow. Alternative target sites may include other body tissues or body cavities. Use of apparatus 20 to deliver medication or fluid may be applied to any desirable sites in the body.
After preparing a selected target site, for example a humeral head or a proximal tibia, apparatus 20 may be seated with first end 58a of retractable sleeve 58 disposed against skin overlying a bone and bone marrow at the target site for insertion of bone penetrating needle 160. Switch or trigger 32 may be activated to begin drilling into the bone and adjacent target bone marrow. See
After medication or fluid delivery, apparatus 20 may be disengaged from cartridge assembly 130. Reservoir 132 may then be detached from hub 300. Bone marrow may then be accessed through a connector attached with second end 302 of hub 300. See
Apparatus 220 as shown in
Apparatus 220, as shown in
Housing 222 may include handle 224 which has been sized and contoured to fit the hand of an operator (not expressly shown). Handle 224 may include on/off switch or trigger 232. Drive shaft 238 may extend from first end 227 of housing 222. Second end 228 of housing 222 may be sealed or closed to protect various components such as a motor, gearbox or gear head and a power source that may be disposed within housing 222.
Examples of power drivers satisfactory for use with a plunger operating and cartridge drive assembly incorporating teachings of the present disclosure are shown in U.S. Pat. No. 6,183,442 entitled “Tissue Penetrating Device and Methods of Using Same” and U.S. Pat. No. 5,554,154 entitled “Intra-Osseous Needle Drill.” Power drivers which may also be satisfactorily used with a plunger assembly incorporating teachings of the present disclosure are shown in U.S. patent application Ser. No. 10/449,530 entitled “Apparatus and Method to Provide Emergency Access to Bone Marrow” filed May 30, 2003 and U.S. patent application Ser. No. 10/449,476 entitled “Apparatus and Method to Access Bone Marrow” filed May 30, 2003. Manual drivers (not expressly shown) may also be satisfactorily used with cartridge drive mechanisms and/or plunger operating assemblies incorporating teachings of the present disclosure to provide access to bone marrow or other target sites in a patient's body.
Plunger operating and cartridge drive mechanism 250 may include first spring 251 and second spring. First spring 251 may sometimes be referred to as “plunger spring” 251. Second spring 252 may sometimes be referred to as “retractable sleeve spring” 252. One or more additional springs may also be disposed within plunger operating and cartridge drive mechanism 250 depending upon mechanisms used to releasably retain a cartridge assembly within plunger operating and cartridge drive mechanism 250 and/or allow plunger operating assembly 280 to move from a first, cocked position to a second, uncocked position.
Plunger operating assembly 280 may be disposed within longitudinal bore 256 of plunger operating and drive mechanism 250 adjacent to second end 254b. Plunger operating assembly 280 may include plunger barrel 282. Plunger barrel 282 may include chamber or cavity 292 which is sized to receive portions of a plunger assembly therein. Plunger operating assembly 280 may be moved from an uncocked position (not expressly shown) to a cocked position such as shown in
First end or distal end 258a of retractable sleeve 258 may then be placed adjacent to a selected target site. Switch 232 may be depressed to activate driver 221 to rotate drive shaft 238 and insert bone penetrating needle 160 to a desired depth at the target site. As bone penetrating needle 160 is inserted into the target site, retractable sleeve 258 will move longitudinally from a first, extended position to a second, retracted position which results in release of plunger operating assembly 280 from its first, cocked position and allows first spring or plunger spring 251 to force plunger assembly 140a to move from its first position to its second position which results in the injection of fluids contained within reservoir 132a into bone marrow at the selected target site. After plunger assembly 140a has completed injection of the fluid, various release mechanisms such as shown in
Plunger operating and cartridge drive mechanism 250 may also include drive housing 254 defined in part by first end 254a and second end 254b. Drive housing 254 may have a generally hollow cylindrical configuration defined in part by longitudinal bore 256 extending from first end 254a towards second end 254b. Retractable sleeve 258 may be slidably disposed within longitudinal bore 256 and extend from first end 254a. Retractable sleeve 258 may also include first end or distal end 258a and second end or proximal end 258b. The outside diameter of retractable sleeve 258 and the inside diameter of longitudinal bore 256 are preferably selected to allow longitudinal sliding movement of retractable sleeve 258 from its first, extended position as shown in
Second end 254b of drive housing 254 may be generally closed except for opening 262 which is preferably sized to receive drive shaft 23S. Rotation of drive shaft 23S may be transmitted through portions of drive housing 250 adjacent to opening 256. Drive housing 254 may be used to transmit rotational forces or drilling forces from drive shaft 23S to a cartridge assembly releasably engaged with plunger operating and cartridge drive mechanism 250.
Plunger barrel 82a may include recess or groove 188 formed on the exterior thereof. As an associated plunger barrel 82a is shifted from a cocked position to a released position, groove 188 will be aligned with second end 186 of collet fingers 182. The dimensions of groove 188 are preferably selected to allow second end 186 of each collet finger 182 to be received therein. An associated retractable sleeve (not expressly shown) may include an enlarged inside diameter portion which accommodates radial expansion of collet fingers 182 and associated collet heads 184 to release their engagement with drive connector 150a. As a result the associated drive apparatus may be removed from cartridge assembly 130a.
Plunger shaft or plunger rod 142b may include recess or groove 176 formed on the exterior thereof. As an associated plunger barrel (not expressly shown) moves from a cocked position to a released position, recess or groove 176 will be aligned with balls 172a and second end 1S6a of each collet finger 182a. The dimensions of recess 176 are preferably selected to allow balls 172a to be received therein. An associated retractable sleeve (not expressly shown) may include an enlarged inside diameter portion which accommodates radial expansion of collet fingers 182a and associated collet heads 184a to release their engagement with drive connector 150a. As a result, the associated drive apparatus may be removed from cartridge assembly 130a.
Apparatus 20 or 220 may be used to access the bone marrow of any bone in the body including but not limited to the tibia, humeral head, or sternum. Apparatus 20 or 220 may be used to access the femur, radius, ulna, iliac crest and medial malleolus or any other target site in a body including non-bony targets. Apparatus 20 or 220 may be used to access the bones and bone marrow of adults, children and any animal species. Apparatus 20 or 200 may also be used to access other tissues or body cavities.
Apparatus 20 and 220 may be used to administer a unit dose of medication to bone marrow or other target sites in any form suitable for delivery. Such drugs include, but are not limited to medications for resuscitation during the treatment of cardiac arrest, antibiotics, poison antidotes, nerve gas antidotes and radio protectants to protect the body against radiation exposure. Apparatus 20 or 220 may be used to administer any suitable fluids or other substances suitable for injection into bone marrow or other sites in the body. Such fluids may include, but are not limited to, normal saline, lactated Ringer's solution, blood, plasma, albumin or any other bio-compatible fluid.
Apparatus 20 and 220 formed in accordance with teachings of the present disclosure may have ergonomic designs that allow insertion pressure or forces, such as rotational, drilling, impact, longitudinal, and/or manual forces, to be applied with relative ease and at the same time permit insertion of a bone penetrator extending from an associated cartridge assembly. Handle 22 and 222 may be aligned with an anatomically neutral position of an operator's hand and wrist as a powered driver rotates a releasably engaged cartridge assembly with a bone penetrator extending therefrom. This alignment may allow better axial orientation of apparatus 20 and 220 as an associated bone penetrator is inserted into bone marrow or other target site with less chance of excessive movement and/or misalignment of the bone penetrator which might result in undesired widening and/or elongation of an associated insertion hole.
Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions and alternations can be made herein without departing from the spirit and scope of the disclosure as defined by the following claims.
This application is a continuation application of U.S. patent application Ser. No. 12/718,638, filed Mar. 5, 2010, which is a divisional application of U.S. patent application Ser. No. 12/347,506, filed Dec. 31, 2008, now U.S. Pat. No. 8,038,664, which is a divisional application of U.S. patent application Ser. No. 11/190,331, filed Jul. 27, 2005, now U.S. Pat. No. 7,811,260, which is a continuation-in-part application of U.S. patent application Ser. No. 10/449,503, filed May 30, 2003, now U.S. Pat. No. 7,670,328, which claims the benefit of U.S. Provisional Patent Application No. 60/384,756, filed May 31, 2002, the contents of which are hereby incorporated in their entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
1539637 | Bronner | May 1925 | A |
1954620 | Connell | Apr 1934 | A |
2317648 | Siqveland | Apr 1943 | A |
2419045 | Whittaker | Apr 1947 | A |
2766907 | Wallace, Jr. | Oct 1956 | A |
2773501 | Young | Dec 1956 | A |
2660635 | Wilburn | Nov 1958 | A |
3104448 | Morrow et al. | Sep 1963 | A |
3120845 | Horner | Feb 1964 | A |
3173417 | Horner | Mar 1965 | A |
3175554 | Stewart | Mar 1965 | A |
3507276 | Burgess et al. | Apr 1970 | A |
3529580 | Stevens | Sep 1970 | A |
3543966 | Ryan et al. | Dec 1970 | A |
3697223 | Kovalcik | Oct 1972 | A |
3734207 | Fishbein | May 1973 | A |
3750667 | Pshenichny et al. | Aug 1973 | A |
3802555 | Grasty et al. | Apr 1974 | A |
3815605 | Schmidt et al. | Jun 1974 | A |
3835860 | Garretson | Sep 1974 | A |
3893445 | Hofsess | Jul 1975 | A |
3935909 | Mabuchi et al. | Feb 1976 | A |
3991765 | Cohen | Nov 1976 | A |
4021920 | Kirschner et al. | May 1977 | A |
4099518 | Baylis et al. | Jul 1978 | A |
4124026 | Berner et al. | Nov 1978 | A |
4142517 | Stavropoulos et al. | Mar 1979 | A |
4170993 | Alvarez | Oct 1979 | A |
4185619 | Reiss | Jan 1980 | A |
4194505 | Schmitz | Mar 1980 | A |
4258722 | Sessions et al. | Mar 1981 | A |
4262676 | Jamshidi | Apr 1981 | A |
4266555 | Jamshidi | May 1981 | A |
4306570 | Matthews | Dec 1981 | A |
4333459 | Becker | Jun 1982 | A |
4359052 | Staub | Nov 1982 | A |
4381777 | Garnier | May 1983 | A |
4399723 | Marleau | Aug 1983 | A |
4413760 | Paton | Nov 1983 | A |
4420085 | Wilson et al. | Dec 1983 | A |
4441563 | Walton, II | Apr 1984 | A |
4469109 | Mehl | Sep 1984 | A |
4484577 | Sackner et al. | Nov 1984 | A |
4487209 | Mehl | Dec 1984 | A |
4504267 | Parmelee et al. | Mar 1985 | A |
4543966 | Islam et al. | Oct 1985 | A |
4553539 | Morris | Nov 1985 | A |
4578064 | Sarnoff et al. | Mar 1986 | A |
4605011 | Naslund | Aug 1986 | A |
4620539 | Andrews et al. | Nov 1986 | A |
4630616 | Tretinyak | Dec 1986 | A |
4646731 | Brower | Mar 1987 | A |
4654492 | Koerner et al. | Mar 1987 | A |
4655226 | Lee | Apr 1987 | A |
4659329 | Annis | Apr 1987 | A |
4692073 | Martindell | Sep 1987 | A |
4711636 | Bierman | Dec 1987 | A |
4713061 | Tarello et al. | Dec 1987 | A |
4716901 | Jackson et al. | Jan 1988 | A |
4723945 | Theiling | Feb 1988 | A |
4736850 | Bowman et al. | Apr 1988 | A |
4758225 | Cox et al. | Jul 1988 | A |
4762118 | Lia et al. | Aug 1988 | A |
4772261 | Von Hoff et al. | Sep 1988 | A |
4787893 | Villette | Nov 1988 | A |
4793363 | Ausherman et al. | Dec 1988 | A |
4838282 | Strasser et al. | Jun 1989 | A |
4844259 | Glowczewskie et al. | Jul 1989 | A |
4867158 | Sugg | Sep 1989 | A |
4919146 | Rhinehart et al. | Apr 1990 | A |
4921013 | Spalink et al. | May 1990 | A |
4922602 | Mehl | May 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4940459 | Noce | Jul 1990 | A |
4944677 | Alexandre | Jul 1990 | A |
4969870 | Kramer et al. | Nov 1990 | A |
4986279 | O'Neill | Jan 1991 | A |
5002546 | Romano | Mar 1991 | A |
5025797 | Baran | Jun 1991 | A |
5036860 | Leigh et al. | Aug 1991 | A |
5057085 | Kopans | Oct 1991 | A |
5074311 | Hasson | Dec 1991 | A |
5116324 | Brierley et al. | May 1992 | A |
5120312 | Wigness et al. | Jun 1992 | A |
5122114 | Miller et al. | Jun 1992 | A |
5133359 | Kedem | Jul 1992 | A |
5137500 | Lhotak | Aug 1992 | A |
5137518 | Mersch | Aug 1992 | A |
5139500 | Schwartz | Aug 1992 | A |
RE34056 | Lindgren et al. | Sep 1992 | E |
5145369 | Lustig et al. | Sep 1992 | A |
5172701 | Leigh | Dec 1992 | A |
5172702 | Leigh et al. | Dec 1992 | A |
5176415 | Choksi | Jan 1993 | A |
5176643 | Kramer et al. | Jan 1993 | A |
5195985 | Hall | Mar 1993 | A |
5203056 | Funk et al. | Apr 1993 | A |
5207697 | Carusillo et al. | May 1993 | A |
5249583 | Mallaby | Oct 1993 | A |
5257632 | Turkel et al. | Nov 1993 | A |
5261877 | Fine et al. | Nov 1993 | A |
5269785 | Bonutti | Dec 1993 | A |
5271414 | Partika et al. | Dec 1993 | A |
5279306 | Mehl | Jan 1994 | A |
5312351 | Gerrone | May 1994 | A |
5312364 | Jacobs | May 1994 | A |
5312408 | Brown | May 1994 | A |
5315737 | Ouimet | May 1994 | A |
5324300 | Elias et al. | Jun 1994 | A |
5341316 | Allen | Jun 1994 | A |
5330480 | Meloul et al. | Jul 1994 | A |
5332398 | Miller et al. | Jul 1994 | A |
5333790 | Christopher | Aug 1994 | A |
5334204 | Clewett et al. | Aug 1994 | A |
5341823 | Manosalva et al. | Aug 1994 | A |
5348022 | Legh et al. | Sep 1994 | A |
5356006 | Alpern et al. | Oct 1994 | A |
5357974 | Baldridge | Oct 1994 | A |
5361853 | Takamura et al. | Nov 1994 | A |
5368046 | Scarfone et al. | Nov 1994 | A |
5372583 | Roberts et al. | Dec 1994 | A |
5383859 | Sewell, Jr. | Jan 1995 | A |
5385151 | Scarfone et al. | Jan 1995 | A |
5385553 | Hart et al. | Jan 1995 | A |
5389553 | Grubisich et al. | Feb 1995 | A |
5400798 | Baran | Mar 1995 | A |
5405348 | Anspach et al. | Apr 1995 | A |
5405362 | Kramer et al. | Apr 1995 | A |
5423824 | Akerfeldt et al. | Jun 1995 | A |
5431655 | Melker et al. | Jul 1995 | A |
5451210 | Kramer et al. | Sep 1995 | A |
5484442 | Melker et al. | Jan 1996 | A |
5505737 | Gosselin et al. | Apr 1996 | A |
D369858 | Baker et al. | May 1996 | S |
5514097 | Knauer | May 1996 | A |
5526821 | Jamshidi | Jun 1996 | A |
5529580 | Kusunoki et al. | Jun 1996 | A |
5549565 | Ryan et al. | Aug 1996 | A |
5554154 | Rosenberg | Sep 1996 | A |
5556399 | Huebner | Sep 1996 | A |
5558737 | Brown et al. | Sep 1996 | A |
5571133 | Yoon | Nov 1996 | A |
5586847 | Mattern et al. | Dec 1996 | A |
5591188 | Waisman | Jan 1997 | A |
5595186 | Rubinstein et al. | Jan 1997 | A |
5601559 | Melker et al. | Feb 1997 | A |
5624214 | Carroll | Apr 1997 | A |
5632747 | Scarborough et al. | May 1997 | A |
5651419 | Holzer et al. | Jul 1997 | A |
5672155 | Riley et al. | Sep 1997 | A |
5709275 | Neumaier | Jan 1998 | A |
5713368 | Leigh | Feb 1998 | A |
5724873 | Hillinger | Mar 1998 | A |
5733262 | Paul | Mar 1998 | A |
5752923 | Terwilliger | May 1998 | A |
5762639 | Gibbs | Jun 1998 | A |
5766221 | Benderev et al. | Jun 1998 | A |
5769086 | Ritchart et al. | Jun 1998 | A |
5779708 | Wu | Jul 1998 | A |
5800389 | Burney et al. | Sep 1998 | A |
5807275 | Jamshidi | Sep 1998 | A |
5807277 | Swaim | Sep 1998 | A |
5810826 | Akerfeldt et al. | Sep 1998 | A |
5817052 | Johnson et al. | Oct 1998 | A |
5823970 | Terwilliger | Oct 1998 | A |
D403405 | Terwilliger | Dec 1998 | S |
5858005 | Kriesel | Jan 1999 | A |
5865711 | Kramer et al. | Feb 1999 | A |
5868711 | Kramer et al. | Feb 1999 | A |
5868750 | Schultz | Feb 1999 | A |
5873499 | Leschinsky et al. | Feb 1999 | A |
5873510 | Hirai et al. | Feb 1999 | A |
5885226 | Rubinstein et al. | Mar 1999 | A |
5891085 | Lilley et al. | Apr 1999 | A |
5911701 | Miller et al. | Jun 1999 | A |
5911708 | Teirstein | Jun 1999 | A |
5916229 | Evans | Jun 1999 | A |
5919172 | Golba, Jr. | Jul 1999 | A |
5921987 | Stone | Jul 1999 | A |
5924864 | Loge et al. | Jul 1999 | A |
5927976 | Wu | Jul 1999 | A |
5928238 | Scarborough et al. | Jul 1999 | A |
5938636 | Kramer et al. | Aug 1999 | A |
5941706 | Ura | Aug 1999 | A |
5941851 | Coffey et al. | Aug 1999 | A |
5951026 | Harman et al. | Sep 1999 | A |
5960797 | Kramer et al. | Oct 1999 | A |
5980469 | Burbank et al. | Nov 1999 | A |
5980545 | Pacala et al. | Nov 1999 | A |
5984020 | Meyer et al. | Nov 1999 | A |
5989257 | Tidwell et al. | Nov 1999 | A |
5993417 | Yerfino et al. | Nov 1999 | A |
5993454 | Longo | Nov 1999 | A |
6007496 | Brannon | Dec 1999 | A |
6017348 | Hart et al. | Jan 2000 | A |
6018094 | Fox | Jan 2000 | A |
6022324 | Skinner | Feb 2000 | A |
6027458 | Janssens | Feb 2000 | A |
6033369 | Goldenberg | Mar 2000 | A |
6033411 | Preissman | Mar 2000 | A |
6063037 | Mittermeier et al. | May 2000 | A |
6071284 | Fox | Jun 2000 | A |
6080115 | Rubinstein et al. | Jun 2000 | A |
6083176 | Terwilliger | Jul 2000 | A |
6086543 | Anderson et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6096042 | Herbert | Aug 2000 | A |
6102915 | Bresier et al. | Aug 2000 | A |
6106484 | Terwilliger | Aug 2000 | A |
6110128 | Andelin et al. | Aug 2000 | A |
6110129 | Terwilliger | Aug 2000 | A |
6110174 | Nichter | Aug 2000 | A |
6120462 | Hibner et al. | Sep 2000 | A |
6126670 | Walker et al. | Oct 2000 | A |
6135769 | Kwan | Oct 2000 | A |
6159163 | Strauss et al. | Dec 2000 | A |
6162203 | Haaga | Dec 2000 | A |
6183442 | Athanasiou et al. | Feb 2001 | B1 |
6210376 | Grayson | Apr 2001 | B1 |
6217561 | Gibbs | Apr 2001 | B1 |
6221029 | Mathis et al. | Apr 2001 | B1 |
6228049 | Schroeder et al. | May 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6238355 | Daum | May 2001 | B1 |
6247928 | Meller et al. | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6257351 | Ark et al. | Jul 2001 | B1 |
6267763 | Castro | Jul 2001 | B1 |
6270087 | Mickel et al. | Aug 2001 | B1 |
6273715 | Meller et al. | Aug 2001 | B1 |
6273862 | Privitera et al. | Aug 2001 | B1 |
6283925 | Terwilliger | Sep 2001 | B1 |
6283970 | Lubinus | Sep 2001 | B1 |
6287114 | Meller et al. | Sep 2001 | B1 |
6302852 | Fleming et al. | Oct 2001 | B1 |
6309358 | Okubo | Oct 2001 | B1 |
6312394 | Fleming | Nov 2001 | B1 |
6315737 | Skinner | Nov 2001 | B1 |
6325806 | Fox | Dec 2001 | B1 |
6328701 | Terwilliger | Dec 2001 | B1 |
6328744 | Harari et al. | Dec 2001 | B1 |
6358252 | Shapira | Mar 2002 | B1 |
6402701 | Kaplan et al. | Jun 2002 | B1 |
6419490 | Kitchings Weathers, Jr. | Jul 2002 | B1 |
6425388 | Embleton et al. | Jul 2002 | B1 |
6428487 | Burdorff et al. | Aug 2002 | B1 |
6443910 | Krueger et al. | Sep 2002 | B1 |
6458117 | Pollins | Oct 2002 | B1 |
6468248 | Gibbs | Oct 2002 | B1 |
6478751 | Krueger et al. | Nov 2002 | B1 |
6488636 | Bryan et al. | Dec 2002 | B2 |
6523698 | Dennehey et al. | Feb 2003 | B1 |
6527736 | Attinoer et al. | Mar 2003 | B1 |
6527778 | Athanasiou et al. | Mar 2003 | B2 |
6540694 | Van Bladel et al. | Apr 2003 | B1 |
6540697 | Chen | Apr 2003 | B2 |
6547511 | Adams | Apr 2003 | B1 |
6547561 | Meller et al. | Apr 2003 | B2 |
6550786 | Gifford et al. | Apr 2003 | B2 |
6554779 | Viola et al. | Apr 2003 | B2 |
6555212 | Boiocchi et al. | Apr 2003 | B2 |
6572563 | Ouchi | Jun 2003 | B2 |
6575745 | Meller et al. | Jun 2003 | B2 |
6575919 | Reiley et al. | Jun 2003 | B1 |
6582399 | Smith et al. | Jun 2003 | B1 |
6585622 | Shum et al. | Jul 2003 | B1 |
6595911 | LoVuolo | Jul 2003 | B2 |
6595979 | Epstein et al. | Jul 2003 | B1 |
6613054 | Scribner et al. | Sep 2003 | B2 |
6616632 | Sharp et al. | Sep 2003 | B2 |
6620111 | Stehens et al. | Sep 2003 | B2 |
6626848 | Nueenfeldt | Sep 2003 | B2 |
6626887 | Wu | Sep 2003 | B1 |
6638235 | Miller et al. | Oct 2003 | B2 |
6656133 | Voegele et al. | Dec 2003 | B2 |
6689072 | Kaplan et al. | Feb 2004 | B2 |
6702760 | Krause et al. | Mar 2004 | B2 |
6702761 | Damadian et al. | Mar 2004 | B1 |
6706016 | Cory et al. | Mar 2004 | B2 |
6716192 | Orosz, Jr. | Apr 2004 | B1 |
6716215 | David et al. | Apr 2004 | B1 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6730043 | Krueger et al. | May 2004 | B2 |
6730044 | Stephens et al. | May 2004 | B2 |
6749576 | Bauer | Jun 2004 | B2 |
6752768 | Burdorff et al. | Jun 2004 | B2 |
6752816 | Culp et al. | Jun 2004 | B2 |
6758824 | Miller et al. | Jul 2004 | B1 |
6761726 | Findlay et al. | Jul 2004 | B1 |
6796957 | Carpenter et al. | Sep 2004 | B2 |
6839789 | Lehwalder et al. | Jan 2005 | B2 |
6846314 | Shapira | Jan 2005 | B2 |
6849051 | Sramek et al. | Feb 2005 | B2 |
6855148 | Foley et al. | Feb 2005 | B2 |
6860860 | Viola | Mar 2005 | B2 |
6871759 | Rake et al. | Mar 2005 | B2 |
6875183 | Cervi | Apr 2005 | B2 |
6875219 | Arramon et al. | Apr 2005 | B2 |
6884245 | Spranza | Apr 2005 | B2 |
6887209 | Kadziauskas et al. | May 2005 | B2 |
6890308 | Islam | May 2005 | B2 |
6905466 | Gibbs | Jun 2005 | B2 |
6930461 | Ruthowski | Aug 2005 | B2 |
6942669 | Kurc | Sep 2005 | B2 |
6969373 | Schwartz et al. | Nov 2005 | B2 |
7001342 | Faciszewski | Feb 2006 | B2 |
7008381 | Janssens | Mar 2006 | B2 |
7008383 | Damadian et al. | Mar 2006 | B1 |
7008394 | Geise et al. | Mar 2006 | B2 |
7018343 | Plishka | Mar 2006 | B2 |
7025732 | Thompson et al. | Apr 2006 | B2 |
7063672 | Schramm | Jun 2006 | B2 |
7081123 | Merboth et al. | Jul 2006 | B2 |
7137985 | Jahng | Nov 2006 | B2 |
7186257 | Kim | Mar 2007 | B2 |
7207949 | Miles et al. | Apr 2007 | B2 |
7226450 | Athanasiou et al. | Jun 2007 | B2 |
7229401 | Kindlein | Jun 2007 | B2 |
7278972 | Lamoureux et al. | Oct 2007 | B2 |
7331930 | Faciszewski | Feb 2008 | B2 |
7565935 | Phillips | Jul 2009 | B1 |
7670328 | Miller | Mar 2010 | B2 |
7699850 | Miller | Apr 2010 | B2 |
7811260 | Miller et al. | Oct 2010 | B2 |
7815642 | Miller | Oct 2010 | B2 |
7850620 | Miller et al. | Dec 2010 | B2 |
7951089 | Miller | May 2011 | B2 |
7988643 | Hoffmann et al. | Aug 2011 | B2 |
8038664 | Miller et al. | Oct 2011 | B2 |
8142365 | Miller | Mar 2012 | B2 |
8217561 | Fukuzawa et al. | Jul 2012 | B2 |
8308693 | Miller et al. | Nov 2012 | B2 |
8419683 | Miller et al. | Apr 2013 | B2 |
8480632 | Miller et al. | Jul 2013 | B2 |
8506568 | Miller | Aug 2013 | B2 |
8641715 | Miller | Feb 2014 | B2 |
8656929 | Miller et al. | Feb 2014 | B2 |
8668698 | Miller et al. | Mar 2014 | B2 |
8684978 | Miller et al. | Apr 2014 | B2 |
8690791 | Miller | Apr 2014 | B2 |
8715287 | Miller | May 2014 | B2 |
8812101 | Miller et al. | Aug 2014 | B2 |
8870872 | Miller | Oct 2014 | B2 |
8876826 | Miller | Nov 2014 | B2 |
8944069 | Miller et al. | Feb 2015 | B2 |
8974410 | Miller et al. | Mar 2015 | B2 |
8998348 | Miller et al. | Apr 2015 | B2 |
9072543 | Miller et al. | Jul 2015 | B2 |
9078637 | Miller | Jul 2015 | B2 |
9295487 | Miller et al. | Mar 2016 | B2 |
9717847 | Miller et al. | Aug 2017 | B2 |
20010005778 | Ouchi | Jun 2001 | A1 |
20010014439 | Meller et al. | Aug 2001 | A1 |
20010026051 | Gifford et al. | Oct 2001 | A1 |
20010047183 | Privitera et al. | Nov 2001 | A1 |
20010053888 | Athanasiou | Dec 2001 | A1 |
20020042581 | Cervi | Apr 2002 | A1 |
20020055713 | Gibbs | May 2002 | A1 |
20020120212 | Ritchart et al. | Aug 2002 | A1 |
20020133148 | Daniel et al. | Sep 2002 | A1 |
20020138021 | Pflueger | Sep 2002 | A1 |
20020143269 | Neuenfeldt | Oct 2002 | A1 |
20020151821 | Castellacci | Oct 2002 | A1 |
20020151902 | Riedel et al. | Oct 2002 | A1 |
20020158102 | Patton et al. | Oct 2002 | A1 |
20030028146 | Aves | Feb 2003 | A1 |
20030032939 | Gibbs | Feb 2003 | A1 |
20030036747 | Ie et al. | Feb 2003 | A1 |
20030050574 | Krueger | Mar 2003 | A1 |
20030078586 | Shapira | Apr 2003 | A1 |
20030114858 | Athanasiou et al. | Jun 2003 | A1 |
20030125639 | Fisher et al. | Jul 2003 | A1 |
20030153842 | Lamoureux et al. | Aug 2003 | A1 |
20030191414 | Reiley et al. | Oct 2003 | A1 |
20030195436 | Van Bladel et al. | Oct 2003 | A1 |
20030195524 | Barner | Oct 2003 | A1 |
20030199787 | Schwindt | Oct 2003 | A1 |
20030199879 | Spranza | Oct 2003 | A1 |
20030216667 | Viola | Nov 2003 | A1 |
20030225344 | Miller | Dec 2003 | A1 |
20030225364 | Kraft et al. | Dec 2003 | A1 |
20030225411 | Miller | Dec 2003 | A1 |
20040019297 | Angel | Jan 2004 | A1 |
20040019299 | Ritchart et al. | Jan 2004 | A1 |
20040034280 | Privitera et al. | Feb 2004 | A1 |
20040049128 | Miller et al. | Mar 2004 | A1 |
20040064136 | Papineau et al. | Apr 2004 | A1 |
20040073139 | Hirsch et al. | Apr 2004 | A1 |
20040092946 | Bagga et al. | May 2004 | A1 |
20040127814 | Negroni | Jul 2004 | A1 |
20040153003 | Cicenas et al. | Aug 2004 | A1 |
20040158172 | Hancock | Aug 2004 | A1 |
20040158173 | Voegele et al. | Aug 2004 | A1 |
20040162505 | Kaplan et al. | Aug 2004 | A1 |
20040191897 | Muschler | Sep 2004 | A1 |
20040210161 | Burdorff et al. | Oct 2004 | A1 |
20040210198 | Shih | Oct 2004 | A1 |
20040215102 | Ikehara et al. | Oct 2004 | A1 |
20040220497 | Findlay et al. | Nov 2004 | A1 |
20040249389 | Kim | Dec 2004 | A1 |
20050027210 | Miller | Feb 2005 | A1 |
20050040060 | Anderson et al. | Feb 2005 | A1 |
20050075581 | Schwindt | Apr 2005 | A1 |
20050085838 | Thompson et al. | Apr 2005 | A1 |
20050101880 | Cicenas et al. | May 2005 | A1 |
20050113716 | Mueller, Jr. et al. | May 2005 | A1 |
20050119660 | Bourlion et al. | Jun 2005 | A1 |
20050124915 | Eggers et al. | Jun 2005 | A1 |
20050131345 | Miller | Jun 2005 | A1 |
20050148940 | Miller | Jul 2005 | A1 |
20050165328 | Heske et al. | Jul 2005 | A1 |
20050165403 | Miller | Jul 2005 | A1 |
20050165404 | Miller | Jul 2005 | A1 |
20050171504 | Miller | Aug 2005 | A1 |
20050182394 | Spero et al. | Aug 2005 | A1 |
20050200087 | Vasudeva et al. | Sep 2005 | A1 |
20050203439 | Heske et al. | Sep 2005 | A1 |
20050209530 | Pflueger | Sep 2005 | A1 |
20050215921 | Hibner et al. | Sep 2005 | A1 |
20050228309 | Fisher et al. | Oct 2005 | A1 |
20050261693 | Miller et al. | Nov 2005 | A1 |
20060011506 | Riley | Jan 2006 | A1 |
20060015066 | Turieo et al. | Jan 2006 | A1 |
20060036212 | Miller | Feb 2006 | A1 |
20060052790 | Miller | Mar 2006 | A1 |
20060074345 | Hibner | Apr 2006 | A1 |
20060079774 | Anderson | Apr 2006 | A1 |
20060089565 | Schramm | Apr 2006 | A1 |
20060122535 | Daum | Jun 2006 | A1 |
20060129082 | Rozga | Jun 2006 | A1 |
20060144548 | Beckman et al. | Jul 2006 | A1 |
20060149163 | Hibner et al. | Jul 2006 | A1 |
20060167377 | Richart et al. | Jul 2006 | A1 |
20060167378 | Miller | Jul 2006 | A1 |
20060167379 | Miller | Jul 2006 | A1 |
20060189940 | Kirsch | Aug 2006 | A1 |
20060206132 | Conquergood et al. | Sep 2006 | A1 |
20070016100 | Miller | Jan 2007 | A1 |
20070149920 | Michels et al. | Jun 2007 | A1 |
20070213735 | Sandat et al. | Sep 2007 | A1 |
20070270775 | Miller et al. | Nov 2007 | A1 |
20080015467 | Miller | Jan 2008 | A1 |
20080015468 | Miller | Jan 2008 | A1 |
20080045857 | Miller et al. | Feb 2008 | A1 |
20080045860 | Miller et al. | Feb 2008 | A1 |
20080045861 | Miller et al. | Feb 2008 | A1 |
20080045965 | Miller et al. | Feb 2008 | A1 |
20080140014 | Miller et al. | Jun 2008 | A1 |
20080177200 | Ikehara et al. | Jul 2008 | A1 |
20080215056 | Miller et al. | Sep 2008 | A1 |
20080221580 | Miller et al. | Sep 2008 | A1 |
20090069716 | Freeman et al. | Mar 2009 | A1 |
20090093677 | Smith | Apr 2009 | A1 |
20090248029 | Paulos | Oct 2009 | A1 |
20100204611 | Zambelli | Aug 2010 | A1 |
20100298784 | Miller | Nov 2010 | A1 |
20110046507 | Herndon | Feb 2011 | A1 |
20110082387 | Miller et al. | Apr 2011 | A1 |
20110184425 | Cheraux | Jul 2011 | A1 |
20110203821 | Puzio et al. | Aug 2011 | A1 |
20110251518 | Swisher et al. | Oct 2011 | A1 |
20110306841 | Lozman et al. | Dec 2011 | A1 |
20120165832 | Oostman et al. | Jun 2012 | A1 |
20150129456 | Miller et al. | May 2015 | A1 |
20150223786 | Morgan et al. | Aug 2015 | A1 |
Number | Date | Country |
---|---|---|
2138842 | Jun 1996 | CA |
2 454 600 | Jan 2004 | CA |
2664675 | Dec 2004 | CN |
2320209 | May 2009 | CN |
10057931 | Nov 2000 | DE |
517000 | Dec 1992 | EP |
0807412 | Nov 1997 | EP |
1099450 | May 2001 | EP |
1314452 | May 2003 | EP |
1447050 | Aug 2004 | EP |
1421907 | Oct 2010 | EP |
853349 | Mar 1940 | FR |
2457105 | May 1979 | FR |
2516386 | Nov 1981 | FR |
629 824 | Sep 1949 | GB |
2130890 | Jun 1984 | GB |
59119808 | Aug 1984 | JP |
6132663 | Sep 1986 | JP |
1052433 | Feb 1989 | JP |
2001505076 | Apr 2001 | JP |
9208410 | May 1992 | WO |
9307819 | Apr 1993 | WO |
9325151 | Dec 1993 | WO |
9631164 | Oct 1996 | WO |
9806337 | Feb 1998 | WO |
9852638 | Nov 1998 | WO |
9918866 | Apr 1999 | WO |
9952444 | Oct 1999 | WO |
0009024 | Feb 2000 | WO |
0056220 | Sep 2000 | WO |
200178590 | Oct 2001 | WO |
0193931 | Dec 2001 | WO |
0241792 | May 2002 | WO |
02096497 | Dec 2002 | WO |
03015637 | Feb 2003 | WO |
2005072625 | Aug 2005 | WO |
2005110259 | Nov 2005 | WO |
2005112800 | Dec 2005 | WO |
2008033874 | Mar 2008 | WO |
2008081438 | Jul 2008 | WO |
2009070896 | Jun 2009 | WO |
2011070593 | Jun 2011 | WO |
2011123703 | Oct 2011 | WO |
2012175946 | Dec 2012 | WO |
Entry |
---|
International Preliminary Report on Patentabilty, PCT/US2007/072202, 10 pages, dated Jan. 15, 2009. |
International Preliminary Report on Patentability, PCT/US2007/072217, 11 pages, dated Feb. 12, 2009. |
Official Action for European Application No. 03756317.8 (4 pages), dated Dec. 28, 2006. |
Invitation to Pay Additional Fees for Application No. PCT/US2006/025201 (6 pages), dated Oct. 26, 2006. |
Australian Exam Report on Patent Application No. 2003240970, 2 pages, dated Oct. 15, 2007. |
International Search Report and Written Opinion for International Application No. PCT/US2006/025201 (18 pages), dated Jan. 29, 2007. |
International Search Report, PCT/US2007/072209, 9 pages, dated Mar. 12, 2007. |
International Search Report, PCT/US2007/072217, 9 pages, dated Mar. 12, 2007. |
Preliminary Report on Patentability, PCT/US2006/025201, 12 pages, dated Feb. 7, 2008. |
Gunal et al., Compartment Syndrome After Intraosseous Infusion: An Experimental Study in Dogs, Journal od Pediatric Surgery, vol. 31, No. 11, pp. 1491-1493, Nov. 1996. |
International Search Report, PCT/US2007/072217, 20 pages dated Mar. 31, 2008. |
International Search Report, PCT/US2007/072209, 18 pages, dated Apr. 25, 2008. |
Communication Pursuant to Article 94(3) EPC, Application No. 05 712 091.7-1265, 4 pages, dated Apr. 8, 2008. |
Notification of the Chinese Office Action, Application No. 200580003261.81, 3 pages, dated Mar. 1, 2008. |
International Search Report and Written Opinion, PCT/US08/500346, 12 pages, dated May 22, 2008. |
Chinese Office Action, Application No. 2005800003261, (with English translation), (9 pgs), dated Jan. 16, 2009. |
Japanese Office Action, Application No. 2004-508,670, (with English summary), (13 pages), dated Apr. 21, 2009. |
PCT Preliminary Report on Patentability, PCT/US/2008/050346, (8 pgs), dated Jul. 23, 2009. |
European Office Action and Search Report, Application No. 09150973. 7, 8 pages, dated Oct. 23, 2009. |
International Preliminary Report on Patentability, PCT/US08/52943, 7 pages, dated Oct. 15, 2009. |
Japanese Office Action, Application No. 2004-508,669, (with English summary), (9 pages), dated Aug. 3, 2009. |
Chinese Office Action, Application No. 200780000590.6, (with English translation), (13 pages), dated Aug. 21, 2009. |
International Preliminary Report on Patentability PCT/US2005/002484, 9 pages, dated Aug. 3, 2006. |
International PCT Search Report and Written Opinion PCT/US2004/037753, 16 pages, dated Jul. 8, 2005. |
International PCT Search Report and Written Opinion PCT/US2005/002484, 15 pages, dated Jul. 22, 2005. |
International Preliminary Report on Patentability, PCT/US/2007/078203, 13 pages, dated Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078207, 10 pages, dated Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078205, 10 pages, dated Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078204, 11 pages, dated Apr. 2, 2009. |
Vidacare Corporation Comments to Intraosseous Vascular Access Position Paper, Infusion Nurses Society, 6 pages, May 4, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/072209, 10 pages, dated May 14, 2009. |
Communication relating to the results of the partial International Search Report for PCT/US2005/002484, 6 pages, dated May 19, 2005. |
Richard 0. Cummings et al., “ACLS—Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003. |
International PCT Search Report, PCT/US03/17167, 8 Pages, dated Sep. 16, 2003. |
International PCT Search Report, PCT/US03/17203, 8 Pages, dated Sep. 16, 2003. |
International PCT Search Report PCT/US2004/037753, 6 Pages, dated Apr. 19, 2005. |
Astrom, K.G., “Automatic Biopsy Instruments Used Through a Coaxial Bone Biopsy System with an Eccentric Drill Tip,” Acta Radiologica, 1995; 36:237-242, May 1995. |
Astrom, K. Gunnar 0., “CT-guided Transsternal Core Biopsy of Anterior Mediastinal Masses,” Radiology 1996; 199:564-567, May 1996. |
international PCT Search Report PCT/US03/17167, 3 pages, dated Sep. 16, 2003. |
Communication relating to the results of the partial International Search Report for Mailed PCT/US2005/002484, 6 pages, dated May 19, 2005. |
Cummins, Richard O., et al, “ACLS—Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003. |
Riley et al., “A Pathologist's Perspective on Bone Marrow Aspiration Biopsy: I. Performing a Bone Marrow Examination,” Journal of Clinical Laboratory Analysis 18, pp. 70-90, 2004. |
Pediatrics, Official Journal of the American Academy of Pediatrics, Pediatrics; 2005, American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care of Pediatric and Neonatal Patients: Pediatric Advanced Life Support, Downloaded from www.pediatrics.org. |
Liakat A. Parapia, Trepanning or trephines: a history of bone marrow biopsy, British Journal of Haematology, Haematology, pp. 14-19 2007. |
Pediatric Emergency, Intraosseous Infusion for Administration of Fluids and Drugs, www.cookgroup.com, 1 pg, 2000. |
Michael Trotty, “Technology (A Special Report)—The Wall Street Journal 2008 Technology Innovation Awards—This years winners include: an IV alternative, a better way to make solar panels, a cheap, fuel efficient car and a better way toto see in the dark”, The Wall Street Journal, Factiva, 5 pages, 2008. |
Buckley et al., CT-guided bone biopsy: Initial experience with commercially available hand held Black and Decker drill, European Journal of Radiology 61, pp. 176-180, 2007. |
Hakan et al., CT-guided Bone BiopsyPerformed by Means of Coaxial Bopsy System with an Eccentric Drill, Radiology, pp. 549-552, Aug. 1993. |
European Search Report 08158699.2-1265, 4 pages, Aug. 2008. |
International Search Report and Written Opinion, PCT/US2007/078204, 14 pages, dated May 15, 2008. |
International Search Report and Written Opinion, PCT/US08/52943, 8 pages, dated Sep. 26, 2008. |
European Office Action Communication, Application No. 08158699.2-1265/1967142, 10 pages, dated Nov. 4, 2008. |
PCT Invitation to Pay Additional Fees, PCT/US2007/072209, 9 pages, dated Dec. 3, 2007. |
“Proven reliability for quality bone marrow samples”, Special Procedures, Cardinal Health, 6 pages, 2003. |
F.A.S.T. 1 Intraosseous Infusion System with Depth-Control Mechanism Brochure, 6 pages, 2000. |
BioAccess.corn, Sino le Use Small Bone Power Tool—How It Works, 1 Pg., Jun. 9, 2008. |
International Search Report and Written Opinion, PCT/US2007/078203, 15 pages, dated May 13, 2008. |
International Search Report and Written Opinion, PCT/US2007/072202, 17 pages, dated Mar. 25, 2008. |
International Search Report and Written Opinion, PCT/US2007/078207, 13 pages, dated Apr. 7, 2008. |
International Search Report and Written Opinion, PCT/US2007/078205, 13 pages, dated Sep. 11, 2007. |
European Office Action EP03731475.4, 4 pages, dated Oct. 11, 2007. |
Chinese Office Action w/english translation; Application No. 200680021872.X; pp. 8, dated Nov. 6, 2009. |
Chinese Office Action with English translation; Application No. 200910006631.3; pp. 12, dated Mar. 11, 2010. |
European Extended Search Report, Application No. EP10153350.3, 5 pages, dated Mar. 11, 2010. |
European Extended Search Report, Application No. EP08021732.6, 7 pages, dated Nov. 13, 2009. |
European Office Action; Application No. 09 155 111.9-2310; pp. 3, dated Nov. 25, 2009. |
Chinese Office Action with English translation; Application No. 200380000022.0; pp. 10; dated Dec. 13, 2010. |
Chinese Office Action with English translation; Application No. 200880000022.0; pp. dated Sep. 22, 2011. |
Chinese Office Action with English translation; Application No. 200830000022.0; pp. dated May 25, 2012. |
Chinese Office Action with English translation; Application No. 200730000585.5, pp. 15. |
European Office Action dated Jan. 19, 2011 and Response dated Jul. 21, 2011 , EP Application No. 09150973.7. |
European Office Action dated Dec. 22, 2011 and Response dated Jun. 29, 2012, EP Application No. 09150973.7. |
European Office Action dated Feb. 21, 2007 and Response dated Jun. 27, 2007, EP Application No. 05712091.7. |
European Office Action dated Apr. 3, 2008 and Response dated May 15, 2008, EP Application No. 05712091.7. |
European Office Action dated Sep. 21, 2007 and Response dated Nov. 26, 2007, EP Application No. 05712091.7. |
European Office Action dated Sep. 3, 2010 and Response dated Mar. 17, 2011 , EP Application No. 10153350.3. |
European Telephone Consultation Report dated Apr. 21, 2009 and Response dated Jun. 24, 2009, EP Aoolication No. 08158699.2. |
European Telephone Consultation Report dated Sep. 23, 2009 and Response dated Oct. 28, 2009 , EP Application No. 08158699.2. |
International Search Report and Written Opinion for international application PCT/US2008/0500346. dated May 22, 2008. |
Interview Summary for U.S. Appl. No. 11/190,331. dated Jul. 13, 2009. |
Office Action for Japanese Application No. 2004-508,670 with English Translation, dated Aug. 31, 2010. |
Notice of Allowance in U.S. Appl. No. 11/042,912, dated Sep. 24, 2013. |
Notice of Allowance in U.S. Appl. No. 11/380,340 dated Aug. 22, 2014. |
Notice of Allowance in U.S. Appl. No. 11/619,390 dated Nov. 6, 2014. |
Notice of Allowance in U.S. Appl. No. 11/620,927 dated Jun. 3, 2014. |
Notice of Allowance in U.S. Appl. No. 11/853,678 dated Jul. 11, 2013. |
Notice of Allowance in U.S. Appl. No. 11/853,678, dated Oct. 11, 2013. |
Notice of Allowance in U.S. Appl. No. 11/853,678, dated Nov. 8, 2013. |
Notice of Allowance in U.S. Appl. No. 12/259,745 dated Nov. 7, 2014. |
Notice of Allowance in U.S. Appl. No. 12/331,979, dated Dec. 23, 2013. |
Notice of Allowance in U.S. Appl. No. 12/407,651 dated Jun. 11, 2014. |
Notice of Allowance in U.S. Appl. No. 12/427,310, dated Nov. 29, 2013. |
Notice of Allowance in U.S. Appl. No. 12/899,696 dated Jul. 18, 2013,. |
Notice of Allowance in U.S. Appl. No. 12/899,696, Appl. Nov. 12, 2013. |
Notice of Allowance in U.S. Appl. No. 14/721,144 dated Jul. 22, 2014. |
Notice of Allowance issued in U.S. Appl. No. 11/253,467, dated Mar. 29, 2013. |
Notice of Allowance issued in U.S. Appl. No. 11/253,959, dated May 20, 2013. |
Notice of Allowance dated Mar. 4, 2014 in U.S. Appl. No. 11/253,467. |
Office Action for Canadian application 2,612,483, dated Dec. 27, 2013. |
Office Action for Chinese application 200880000182.5 (English translation). dated Sep. 10, 2010. |
Office Action Action for for Chinese application 200380000182.5 (English translation) dated Jun. 27, 2013. |
Office Action for Chinese application 200880000182.5 with English translation. dated Jun. 27, 2013. |
Office Action for Chinese application 200910006631.3 (English translation). dated Nov. 11, 2010. |
Office Action for Chinese application 200910006631.3. dated Mar. 22, 2011. |
Office Action for for Chinese application 201210169456.0 with English translation. dated Aug. 28, 2013. |
Office Action for Chinese application 201210169546.0 with English translation. dated Apr. 18, 2014. |
Office Action for European application 05712091.7. dated Sep. 21, 2007. |
Office Action for European application 08021732.6. dated Oct. 2, 2013. |
Office Action for European application 08799753.2 dated Sep. 29, 2014. |
Office Action for European Application 09150973.7-1269 dated Dec. 22, 2011. |
Office Action for European application 10153350.3. dated Sep. 8, 2010. |
Office Action for Taiwanese application 093134480 (English Translation). dated Feb. 11, 2011. |
Office Action for Taiwanese application 94102179 (English translation). dated May 13, 2010. |
Office Action for U.S. Appl. No. 10/449,476. dated Oct. 29, 2008. |
Office Action for U.S. Appl. 10/449,476. dated May 29, 2009. |
Office Action for U.S. Appl. No. 10/449,503. dated Apr. 1, 2009. |
Office Action for U.S. Appl. No. 11/042,912. dated Jul. 23, 2009. |
Office Action for U.S. Appl. No. 11/042,912. dated Mar. 19, 2010. |
Office Action for U.S. Appl. No. 11/042,912. dated Nov. 28, 2008. |
Office Action for U.S. Appl. No. 11/064,156. dated Jun. 19, 2009. |
Office Action for U.S. Appl. No. 11/190,331. dated Mar. 23, 2009. |
Office Action for U.S. Appl. No. 11/253,467. dated Apr. 28, 2011. |
Office Action for U.S. Appl. No. 11/253,467. dated Jul. 22, 2010. |
Office Action for U.S. Appl. No. 11/253,467. dated Oct. 29, 2010. |
Office Action for U.S. Appl. No. 11/253,959. dated Aug. 5, 2010. |
Office Action for U.S. Appl. No. 11/253,959. dated Mar. 30, 2011. |
Office Action for U.S. Appl. No. 11/253,959. dated Oct. 18, 2010. |
Office Action for U.S. Appl. No. 11/427,501. dated Aug. 7, 2008. |
Office Action for U.S. Appl. No. 11/427,501. dated May 13, 2009. |
Office Action for U.S. Appl. No. 11/427,501. dated Oct. 21, 2009. |
Office Action for U.S. Appl. No. 11/853,685. dated Jun. 24, 2009. |
Office Action for U.S. Appl. No. 12/259,745. dated Jul. 17, 2009. |
Office Action for U.S. Appl. No. 12/905,659. dated Mar. 21, 2011. |
Office Action for U.S. Appl. No. 12/905,659. dated May 13, 2011. |
Office Action in Canadian Patent Application No. 2,612,433, dated Aug. 22, 2014. |
Office Communication for European application 09150973.7-1269. dated Jan. 19, 2011. |
Office Communication in European Application No. 08021732.6, dated Jul. 20, 2013. |
Office Communication in European Application No. 10153350.3, dated Jun. 14, 2011. |
Request for Continued Examination and Amendment for U.S. Appl. No. 11/731,568, filed Sep. 17, 2009. |
Response to Extended European Search Report in European Application No. 10153350.3, filed Jun. 30, 2010. |
Response to Interview Summary for U.S. Appl. No. 11/190,331 and Amendment. filed Aug. 12, 2009. |
Response to Office Action for European application 10153350.3. Filed Mar. 17, 2011. |
Response to Office Action for U.S. Appl. No. 10/449,476, filed Aug. 12, 2009. |
Response to Office Action for U.S. Appl. No. 10/449,503, filed Jul. 1, 2009. |
Response to Office Action for U.S. Appl. No. 11/190,331, filed Jun. 22, 2009. |
Response to Office Action for U.S. Appl. No. 11/427,501, filed Jul. 1, 2009. |
Response to Office Communication in European Application No. 10153350.3, filed Feb. 9, 2012. |
Special Procedures, Cardinal Health, “Proven reliability for quality bone marrow samples,” 2003. |
European Search Report issued in European Patent Application No. 17198059.2 dated Jan. 29, 2018. |
Number | Date | Country | |
---|---|---|---|
20160184509 A1 | Jun 2016 | US |
Number | Date | Country | |
---|---|---|---|
60384756 | May 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12347506 | Dec 2008 | US |
Child | 12718638 | US | |
Parent | 11190331 | Jul 2005 | US |
Child | 12347506 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12718638 | Mar 2010 | US |
Child | 15064272 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10449503 | May 2003 | US |
Child | 11190331 | US |